173 related articles for article (PubMed ID: 36397212)
21. Association between white matter impairment and cognitive dysfunction in patients with ischemic Moyamoya disease.
Liu Z; He S; Xu Z; Duan R; Yuan L; Xiao C; Yi Z; Wang R
BMC Neurol; 2020 Aug; 20(1):302. PubMed ID: 32799829
[TBL] [Abstract][Full Text] [Related]
22. Predictors of preoperative cognitive dysfunction in adults with Moyamoya disease: a preliminary research.
Sun J; Shi Z; Yu L; Wen Y; Zhang D
BMC Neurol; 2022 Jan; 22(1):12. PubMed ID: 34991523
[TBL] [Abstract][Full Text] [Related]
23. Association between Cognitive Decline and Altered Cerebral Perfusion in Adults with Moyamoya Disease after Revascularization.
Bao Y; Yu F; Wei L; Zhu W; Wang L; Ding H; Yang J; Huang D
Cerebrovasc Dis; 2022; 51(6):764-773. PubMed ID: 35477140
[TBL] [Abstract][Full Text] [Related]
24. Association between White Matter Hyperintensities Burden and Cognitive Function in Adult Asymptomatic Moyamoya Disease.
Shen J; Xu Z; Liu Z; Duan Y; Wei W; Chang J
J Clin Med; 2023 Feb; 12(3):. PubMed ID: 36769790
[No Abstract] [Full Text] [Related]
25. Executive function and diffusion in frontal white matter of adults with moyamoya disease.
Nakamizo A; Kikkawa Y; Hiwatashi A; Matsushima T; Sasaki T
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):457-61. PubMed ID: 23608368
[TBL] [Abstract][Full Text] [Related]
26. Assessment of cognitive function in adult patients with hemorrhagic moyamoya disease who received no surgical revascularization.
Su SH; Hai J; Zhang L; Yu F; Wu YF
Eur J Neurol; 2013 Jul; 20(7):1081-7. PubMed ID: 23577654
[TBL] [Abstract][Full Text] [Related]
27. Long-term study of the cognitive profile of Moyamoya Disease in adults.
Chan E; Gal AM; Van Harskamp N; Adams ME; Brown MM; Werring DJ; Cipolotti L; Simister R
J Stroke Cerebrovasc Dis; 2023 Jun; 32(6):107064. PubMed ID: 36996746
[TBL] [Abstract][Full Text] [Related]
28. Impaired functional recovery of endothelial colony-forming cells from moyamoya disease in a chronic cerebral hypoperfusion rat model.
Choi SA; Chong S; Kwak PA; Moon YJ; Jangra A; Phi JH; Lee JY; Park SH; Kim SK
J Neurosurg Pediatr; 2018 Nov; 23(2):204-213. PubMed ID: 30668528
[TBL] [Abstract][Full Text] [Related]
29. Postoperative executive function in adult moyamoya disease: a preliminary study of its functional anatomy and behavioral correlates.
Lei Y; Li YJ; Guo QH; Liu XD; Liu Z; Ni W; Su JB; Yang H; Jiang HQ; Xu B; Gu YX; Mao Y
J Neurosurg; 2017 Feb; 126(2):527-536. PubMed ID: 27058195
[TBL] [Abstract][Full Text] [Related]
30. The profile of cognitive impairment and hemodynamic compromise in moyamoya: a single-center prospective cohort study.
Kronenburg A; Deckers PT; van den Berg E; van Schooneveld MM; Vonken EJ; van der Zwan A; van Berckel BNM; Yaqub M; Otte W; Klijn CJM; Braun KPJ
J Neurosurg; 2023 Jan; 138(1):173-184. PubMed ID: 35523260
[TBL] [Abstract][Full Text] [Related]
31. Neurocognitive impairment in adults with moyamoya disease without stroke.
Karzmark P; Zeifert PD; Bell-Stephens TE; Steinberg GK; Dorfman LJ
Neurosurgery; 2012 Mar; 70(3):634-8. PubMed ID: 21849919
[TBL] [Abstract][Full Text] [Related]
32. Fronto-Parietal and White Matter Haemodynamics Predict Cognitive Outcome in Children with Moyamoya Independent of Stroke.
Choi EJ; Westmacott R; Kirkham FJ; Robertson A; Muthusami P; Shroff M; Moharir M; Williams T; Dirks P; MacGregor D; Slim M; Pulcine E; Bhathal I; Kaseka ML; Kassner A; Logan W; deVeber G; Dlamini N
Transl Stroke Res; 2022 Oct; 13(5):757-773. PubMed ID: 35338434
[TBL] [Abstract][Full Text] [Related]
33. Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease in Adults with Moyamoya Disease.
Sun H; Li W; Xia C; Ren Y; Ma L; Xiao A; You C; Wang X; Tian R; Liu Y
Transl Stroke Res; 2022 Aug; 13(4):533-542. PubMed ID: 34839443
[TBL] [Abstract][Full Text] [Related]
34.
Weng R; Ren S; Su J; Ni W; Yang C; Gao X; Xiao W; Zhang X; Jiang H; Guan Y; Huang Q; Gu Y
Brain Imaging Behav; 2023 Apr; 17(2):185-199. PubMed ID: 36637715
[TBL] [Abstract][Full Text] [Related]
35. Is local hypoperfusion the reason for transient neurological deficits after STA-MCA bypass for moyamoya disease?
Mukerji N; Cook DJ; Steinberg GK
J Neurosurg; 2015 Jan; 122(1):90-4. PubMed ID: 25343178
[TBL] [Abstract][Full Text] [Related]
36. Neuronal Loss in the Bilateral Medial Frontal Lobe Revealed by
Kikuchi T; Takagi Y; Nakagawara J; Ueno T; Ubukata S; Houkin K; Araki Y; Takahashi JC; Nakase H; Murai T; Miyamoto S;
Neurol Med Chir (Tokyo); 2023 Aug; 63(8):334-342. PubMed ID: 37164699
[TBL] [Abstract][Full Text] [Related]
37. Preliminary study of neurocognitive dysfunction in adult moyamoya disease and improvement after superficial temporal artery-middle cerebral artery bypass.
Baek HJ; Chung SY; Park MS; Kim SM; Park KS; Son HU
J Korean Neurosurg Soc; 2014 Sep; 56(3):188-93. PubMed ID: 25368759
[TBL] [Abstract][Full Text] [Related]
38. Executive dysfunction in adults with moyamoya disease is associated with increased diffusion in frontal white matter.
Calviere L; Ssi Yan Kai G; Catalaa I; Marlats F; Bonneville F; Larrue V
J Neurol Neurosurg Psychiatry; 2012 Jun; 83(6):591-3. PubMed ID: 22378919
[TBL] [Abstract][Full Text] [Related]
39. Asymmetric Cortical Vessel Sign Indicates Hemodynamic Deficits in Adult Patients with Moyamoya Disease.
Weiqiang Q; Tikun S; Qiongqiong Q; Jinge Z; Chunchao X; Yi L; Chao Y
World Neurosurg; 2019 Jul; 127():e137-e141. PubMed ID: 30862600
[TBL] [Abstract][Full Text] [Related]
40. Chronic ischemia alters brain microstructural integrity and cognitive performance in adult moyamoya disease.
Kazumata K; Tha KK; Narita H; Kusumi I; Shichinohe H; Ito M; Nakayama N; Houkin K
Stroke; 2015 Feb; 46(2):354-60. PubMed ID: 25538200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
